Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Nestle's Gerber CEO sees formula shortage improving by October

Published 09/12/2022, 01:29 PM
Updated 09/12/2022, 01:30 PM
© Reuters. Gerber infant formula products are stocked at a Walmart Supercenter in Rogers, Arkansas, U.S., June 4, 2022.  REUTERS/Siddharth Cavale

By Jessica DiNapoli

NEW YORK (Reuters) - Nestle SA (SIX:NESN)'s Gerber Products Company is still in "critical task force mode" due to the U.S. infant formula shortage, its CEO Tarun Malkani said last week, adding that he expects the crunch to improve by October.

Gerber added market share as it pumped out formula to meet the heightened demand during the shortage, caused by supply chain crunches and the closure of an Abbott Laboratories (NYSE:ABT) plant in Michigan, Malkani said last Thursday during a media event at Nestle's U.S. headquarters in Arlington, Virginia.

The Nestle brand, which makes the Good Start line of infant formulas, now has market share of roughly mid-9%, Malkani said. Before the crisis, its market share was around 8.5%, he said.

"We need the marketplace to rebalance," he said.

Availability of powder baby formula, the bulk of the market, has been improving on store shelves, with roughly 79% in stock as of Sept. 4, according to data provider IRI. It reached as low as 69% mid-July, according to IRI.

To ease the shortage, the U.S. government and Food and Drug Administration made it easier for manufacturers to get shipments into the country from overseas.

Gerber "pruned" novelty infant formulas in the beginning of the crisis to focus on those needed most, he said.

Nestle also flew in infant formula supplies from Europe to the United States

Major U.S. retailers including Walmart (NYSE:WMT) Inc and Target Corp (NYSE:TGT) both said last month they have seen formula supplies improve. Target said it was still rationing the product online and in store.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.